Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,881 to 1,900 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype. | Hum Genet | 2019 | 30788592 | PubTator, text mining | PubMed |
| Alternative Splicing in Apicomplexan Parasites. | mBio | 2019 | 30782661 | PubTator, text mining | PubMed |
| Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes. | J Vis Exp | 2019 | 30774126 | PubTator, text mining | PubMed |
| Therapeutic approaches to treat human spliceosomal diseases. | Curr Opin Biotechnol | 2019 | 30772756 | PubTator, text mining | PubMed |
| SAM68 interaction with U1A modulates U1 snRNP recruitment and regulates mTor pre-mRNA splicing. | Nucleic Acids Res | 2019 | 30767021 | PubTator, text mining | PubMed |
| Carrier screening for spinal muscular atrophy with a simple test based on melting analysis. | J Hum Genet | 2019 | 30765868 | PubTator, text mining | PubMed |
| Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases. | Neural Regen Res | 2019 | 30761996 | PubTator, text mining | PubMed |
| Intraperitoneal delivery of a novel drug-like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy. | Sci Rep | 2019 | 30733501 | PubTator, text mining | PubMed |
| Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden. | Pharmacoeconomics | 2019 | 30714083 | PubTator, text mining | PubMed |
| Targeting RNA: A Transformative Therapeutic Strategy. | Clin Transl Sci | 2019 | 30706991 | PubTator, text mining | PubMed |
| Alternative splicing of neuronal genes: new mechanisms and new therapies. | Curr Opin Neurobiol | 2019 | 30703685 | PubTator, text mining | PubMed |
| Human Survival Motor Neuron genes generate a vast repertoire of circular RNAs. | Nucleic Acids Res | 2019 | 30698797 | PubTator, text mining | PubMed |
| A SMN2 Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model. | Stem Cells Dev | 2019 | 30667343 | PubTator, text mining | PubMed |
| SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy. | Orphanet J Rare Dis | 2019 | 30665421 | PubTator, text mining | PubMed |
| Novel challenges in spinal muscular atrophy - How to screen and whom to treat? | Ann Clin Transl Neurol | 2019 | 30656198 | PubTator, text mining | PubMed |
| Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons. | Brain | 2019 | 30649277 | PubTator, text mining | PubMed |
| Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. | Neurotherapeutics | 2019 | 30644073 | PubTator, text mining | PubMed |
| [Spinal muscular atrophy treated with nusinersen]. | Ugeskr Laeger | 2019 | 30618374 | PubTator, text mining | PubMed |
| [Treatment evaluation in patients with 5q-associated spinal muscular atrophy : Real-world experience]. | Nervenarzt | 2019 | 30617569 | PubTator, text mining | PubMed |
| Antisense Transcription in Loci Associated to Hereditary Neurodegenerative Diseases. | Mol Neurobiol | 2019 | 30610612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=95